Asia Pacific Cardiac Pacemaker Market Outlook to 2019 -Ken Research


The Asia-Pacific cardiac pacemaker market is growing at a rapid pace with huge amount of resources being invested in prevention, proper diagnosis and treatment of cancer. In Asia, cardiac disorder has become the main cause of deaths and almost half of world’s cancer deaths occur in Asia. The high incidence of cardiac death rates in Asia can be accounted to heavy pollution, changing age structure, westernized diets and lifestyles and others.

The revenue generated in the Asia cardiac pacemaker market has grown from USD ~ Million in 2009 to USD ~ million in 2014 at a CAGR of ~%.

The cardiac pacemaker market has also faced numerous challenges in terms of increased competition because of rising number of organized and unorganized player in the market thus leading to competition in terms of price and thus negatively affecting the revenue.

The market in the Asia is expected to get intensified further because domestic players in different countries have been increasing their research and development expenditure in order to reduce per unit cost of production and compete with global players in terms of price levels and products offered.


The incidences of cardiovascular diseases in India have been on a steady rise since the past decade. These diseases comprise a major portion of non-communicable diseases and have been the major cause of deaths in the world, accounting for more than a third of the total number of deaths.

In India, the sales of cardiac pacemaker registered a CAGR of ~% during 2009-2014. In 2009, market revenue stood at INR ~ million which grew to INR ~ million in 2014.

The rise in revenue can be attributed to emergence of new and effective pacemakers in the market, rising awareness and others. A major factor that has contributed to such a stupendous growth of this market is advances in technologies.

The major domestic players have consistently adopted diverse strategies in order to maintain their competitive edge. Boston Scientific contributed to ~% of total revenue in FY’2014, whereas Medtronic and MediVed Innovations were other dominant players.


The cardiac pacemaker market in China has observed a major proportion covered by global pharmaceutical companies and a minute proportion dominated by local pharmaceutical companies. Overtime, China’s cardiac pacemaker market has transformed itself to renowned as the largest segment in the pharmaceutical market of China.

The pacemaker market has generated revenues worth USD ~ million in 2009 which grew at rate of 20.0% and reached USD ~ million in 2011. The China pacemaker market revenues have increased at a CAGR of ~% over the period of 5 years from 2009-2014. A major factor contributing to the growth of this market is the growth of ageing population in the China which has a greater susceptibility to cardiac disorders, thus leading to an increase in number of cardiac cases.

In terms of implantability, the internal pacemakers capture major proportion of the market, contributing towards ~% of the total pacemaker market revenue in 2014, amounting for USD ~ million. External pacemakers on the other hand accounted for ~% of the total market, amounting for USD ~ million of total pacemaker sales in 2014

In 2014, single chambered pacemakers captured ~% share of the market, accounting for USD ~ million, whereas double chambered contributed towards ~% of revenue generated by the pacemaker market, amounting to USD ~ million in 2014.


In Japan the high incidence of cardiac disease rates can be accounted to heavy pollution, changing age structure, transformation towards westernized cultures, increasing consumption of tobacco, rising incidence of smoking and others. Japan’s ageing and affluent population represents strong opportunities for pacemaker manufacturers

The sales of cardiac pacemakers were registered as USD ~ million in 2009 which grew at a CAGR of ~% to reach USD ~ million in 2014.

In the manufacturing space, the market for cardiac pacemaker has been dominated by domestic players and very limited numbers of global players are operating in the market. With increase in cardiovascular diseases and greater demand for pacemakers in the market, more number of players are entering into the market.


South Korea has observed a similar trend as other major Asian markets of cardiac pacemakers; where major proportion of the market being covered by global pharmaceutical companies and very less in hands of local pharmaceutical companies.

The sales of pacemaker in South Korea were registered at USD ~ million in 2009 and grew at a CAGR of ~% to reach USD ~ million in 2014. In 2011, sales were reported to be USD ~ million. The sales of pacemaker have showed a continuous upsurge over the years

The rapid market expansion was driven by the strong demand for all types of cardiac equipments. The major drivers which contributed to the growth of pacemaker market were rising prevalence population for major cardiac indications, increased use of pacemakers amongst high class population, expanding rate of urbanization and high unmet need in terms of safer and more efficacious treatment.

Source :

Ken Research
Ankur Gupta, Head Marketing & Communications


Comments are closed.